Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-&ITH30&IT Subclone Among Extraintestinal&IT Escherichia coli&IT Collected From US Children

被引:6
作者
Miles-Jay, Arianna [1 ,2 ]
Weissman, Scott J. [2 ,3 ]
Adler, Amanda L. [2 ]
Tchesnokova, Veronika [4 ]
Sokurenko, Evgeni V. [4 ]
Baseman, Janet G. [1 ]
Zerr, Danielle M. [2 ,3 ]
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98105 USA
[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
E.coli infections; ST131; antimicrobial resistance; pediatric infections; URINARY-TRACT-INFECTION; BETA-LACTAMASE; H30-RX SUBCLONES; UNITED-STATES; CLONAL GROUP; ST131; RISK; COLONIZATION; EMERGENCE; TRAITS;
D O I
10.1093/cid/cix805
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Escherichia coli sequence type (ST) 131-H30 is a globally important pathogen implicated in rising rates of multidrug resistance among E. coli causing extraintestinal infections. Previous studies have focused on adults, leaving the epidemiology of H30 among children undefined. Methods. We used clinical data and isolates from a case-control study of extended-spectrum cephalosporin-resistant E. coli conducted at 4 US children's hospitals to estimate the burden and identify host correlates of infection with H30. H30 isolates were identified using 2-locus genotyping; host correlates were examined using log-binomial regression models stratified by extended-spectrum cephalosporin resistance status. Results. A total of 339 extended-spectrum cephalosporin-resistant and 1008 extended-spectrum cephalosporin-susceptible E. coli isolates were available for analyses. The estimated period prevalence of H30 was 5.3% among all extraintestinal E. coli isolates (95% confidence interval [CI], 4.6%-7.1%); H30 made up 43.3% (81/187) of extended-spectrum beta-lactamase (ESBL)-producing isolates in this study. Host correlates of infection with H30 differed by extended-spectrum cephalosporin resistance status: Among resistant isolates, age <= 5 years was positively associated with H30 infection (relative risk [RR], 1.83 [95% CI, 1.19-2.83]); among susceptible isolates, age <= 5 years was negatively associated with H30 (RR, 0.48 [95% CI, .27-.87]), while presence of an underlying medical condition was positively associated (RR, 4.49 [95% CI, 2.43-8.31]). Conclusions. ST131-H30 is less common among extraintestinal E. coli collected from children compared to reported estimates among adults, possibly reflecting infrequent fluoroquinolone use in pediatrics; however, it is similarly dominant among ESBI-producing isolates. The H30 subclone appears to disproportionately affect young children relative to other extended-spectrum cephalosporin-resistant E. coli.
引用
收藏
页码:411 / 419
页数:9
相关论文
共 34 条
  • [1] [Anonymous], 2014, ANT RES GLOB REP SUR
  • [2] [Anonymous], 2016, MBIO, DOI DOI 10.1128/mBio.02162-15
  • [3] Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
    Banerjee, Ritu
    Robicsek, Ari
    Kuskowski, Michael A.
    Porter, Stephen
    Johnston, Brian D.
    Sokurenko, Evgeni
    Tchesnokova, Veronika
    Price, Lance B.
    Johnson, James R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6385 - 6388
  • [4] The Clonal Distribution and Diversity of Extraintestinal Escherichia coli Isolates Vary According to Patient Characteristics
    Banerjee, Ritu
    Johnston, Brian
    Lohse, Christine
    Chattopadhyay, Sujay
    Tchesnokova, Veronika
    Sokurenko, Evgeni V.
    Johnson, James R.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 5912 - 5917
  • [5] Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts
    Banerjee, Ritu
    Johnston, Brian
    Lohse, Christine
    Porter, Stephen B.
    Clabots, Connie
    Johnson, James R.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (04) : 361 - 369
  • [6] Antibiotic resistance shaping multi-level population biology of bacteria
    Baquero, Fernando
    Tedim, Ana P.
    Coque, Teresa M.
    [J]. FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [7] Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131
    Ben Zakour, Nouri L.
    Alsheikh-Hussain, Areej S.
    Ashcroft, Melinda M.
    Nguyen Thi Khanh Nhu
    Roberts, Leah W.
    Stanton-Cook, Mitchell
    Schembri, Mark A.
    Beatson, Scott A.
    [J]. MBIO, 2016, 7 (02):
  • [8] Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains
    Blanc, Veronique
    Leflon-Guibout, Veronique
    Blanco, Jorge
    Haenni, Marisa
    Madec, Jean-Yves
    Rafignon, Gwenaele
    Bruno, Pascale
    Mora, Azucena
    Lopez, Cecilia
    Dahbi, Ghizlane
    Dunais, Brigitte
    Anastay, Magali
    Branger, Catherine
    Moreau, Richard
    Pradier, Christian
    Nicolas-Chanoine, Marie-Helene
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1231 - 1237
  • [9] The Use of Systemic and Topical Fluoroquinolones
    Bradley, John S.
    Jackson, Mary Anne
    [J]. PEDIATRICS, 2011, 128 (04) : E1034 - E1045
  • [10] Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection
    Das, Sibani
    Adler, Amanda L.
    Miles-Jay, Arianna
    Kronman, Matthew P.
    Qin, Xuan
    Weissman, Scott J.
    Burnham, Carey-Ann D.
    Elward, Alexis
    Newland, Jason G.
    Selvarangan, Rangaraj
    Sullivan, Kaede V.
    Zaoutis, Theoklis
    Zerr, Danielle M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)